Esperion Therapeutics (ESPR) Selling, General & Administrative (2012 - 2026)
Esperion Therapeutics (ESPR) Selling, General & Administrative (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 304.00 Mn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 588.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 184.10 Mn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 318.50 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | 18.03 Mn |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | 381.00 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | 264.59 Mn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 57.53 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 46.94 Mn |
| 10 | Esperion Therapeutics | 49.69 Mn | -118.16 Mn | 45.53 Mn | 43.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43.12 Mn |
| Dec 31, 2025 | 41.43 Mn |
| Sep 30, 2025 | 41.85 Mn |
| Jun 30, 2025 | 39.51 Mn |
| Mar 31, 2025 | 43.00 Mn |
| Dec 31, 2024 | 36.93 Mn |
| Sep 30, 2024 | 39.98 Mn |
| Jun 30, 2024 | 44.19 Mn |
| Mar 31, 2024 | 41.99 Mn |
| Dec 31, 2023 | 45.42 Mn |
| Sep 30, 2023 | 33.24 Mn |
| Jun 30, 2023 | 33.96 Mn |
| Mar 31, 2023 | 29.90 Mn |
| Dec 31, 2022 | 24.14 Mn |
| Sep 30, 2022 | 24.95 Mn |
| Jun 30, 2022 | 29.61 Mn |
| Mar 31, 2022 | 30.38 Mn |
| Dec 31, 2021 | 38.34 Mn |
| Sep 30, 2021 | 39.27 Mn |
| Jun 30, 2021 | 46.32 Mn |